glp 1 receptor agonists and dpp 4 inhibitors Role of DPP-4 in Clinical Practice dpp-4_inhibitors [TUSOM | Pharmwiki]

Chest 141(2 Suppl):e44Se88S Witt DM, Clark NP, Kaatz S, Schnurr T, Ansell JE (2016) Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism

Liu L, Chen J, Wang C, Chen L, Chen L

That's what Phase 3 trials are designed to assess

Although body mass index data were not available for this cohort, our findings suggest that any unmeasured obesity is likely to have been more prevalent in the GLP1 receptor agonist group, with any associated bias potentially moving the estimate towards increased risk of thyroid cancer

Crystal structure of the GLP-1 receptor bound to a peptide agonist (vol 546, pg 254, 2017)

doi: 10.1016/S2213-8587(18)30104-9 43 KohanDEPollockDM